SCHEMBL18786019

SCHEMBL18786019

CC(=O)Oc1ccc(C(=O)OCC(F)(F)S(=O)(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
POLB P06746 1/20 0.44
PKM P14618 1/20 0.44
ELANE P08246 2/20 0.43
HSD17B10 Q99714 1/20 0.42
STS P08842 4/20 0.40
LMNA P02545 2/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.38
ESR1 P03372 1/20 0.38
PGR P06401 1/20 0.38
CHRM2 P08172 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
AR P10275 1/20 0.38
CHRM1 P11229 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
PTGS2 P35354 1/20 0.38
MAPK1 P28482 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10134907 0.87 ELANE (0.47) MAPTPOLBELANESTSKMT2A
SCHEMBL12016472 0.86 CA1 (0.49) MAPTELANESTSSMN1; SMN2NPC1
SCHEMBL7946747 0.84 ELANE (0.49) MAPTPOLBPKMELANEHSD17B10
SCHEMBL10134900 0.84 THRB (0.40) MAPTSTSKMT2AMEN1MAPK1
SCHEMBL18785941 0.83 TP53 (0.45) STSMAPK1HIF1ASMN1; SMN2TP53
SCHEMBL12357120 0.83 ELANE (0.45) MAPTELANESTSLMNAKMT2A
SCHEMBL25455816 0.83 MAPK1 (0.39) MAPTPOLBSTSLMNAKMT2A
SCHEMBL18786029 0.82 GAA (0.49) MAPTPOLBSTSLMNAKMT2A
SCHEMBL18786016 0.81 POLB (0.51) MAPTPOLBHSD17B10STSLMNA
SCHEMBL18785337 0.81 ESR1 (0.50) MAPTLMNAKMT2AMEN1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170115566-A1 RESIST COMPOSITION, PATTERNING PROCESS, AND BARIUM, CESIUM AND CERIUM SALTS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170115566-A1 RESIST COMPOSITION, PATTERNING PROCESS, AND BARIUM, CESIUM AND CERIUM SALTS CASR, LIFR, LBR MAPT 3293/4885POLB 1675/4885PKM 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.